Form 990 for tax year 2024
Filed by MICROBIOME THERAPEUTIC INNOVATION GROUP.
Totals
- Total revenue
- $404,063
- Total expenses
- $478,029
- Contributions and grants received
- $404,056
- Grants paid
- $0
- Program service revenue
- $0
- Investment income
- $7
- Other revenue
- $0
- Total assets, end of year
- $42,287
- Total liabilities, end of year
- $0
- Net assets or fund balances, end of year
- $42,287
- Program services expenses (Part IX)
- $432,676
- Management and general expenses
- $45,353
- Fundraising expenses
- $0
- Program service expenses (Part III)
- $432,676
Program services were 90.5% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1b · Membership dues
$404,056
-
3 · Investment income
total $7 · excluded $7
Functional expenses
Part IX, the statement of functional expenses.
-
11c · Fees: accounting
total $6,942 · management and general $6,942
-
11d · Fees: lobbying
total $432,676 · program services $432,676
-
11g · Fees: other
total $312 · management and general $312
-
12 · Advertising and promotion
total $21,755 · management and general $21,755
-
13 · Office expenses
total $324 · management and general $324
-
17 · Travel
total $413 · management and general $413
-
19 · Conferences, conventions and meetings
total $5,045 · management and general $5,045
-
24a · Other expenses: RESEARCH & DEVELOPMENT
total $10,200 · management and general $10,200
-
24b · Other expenses: BANK CHARGES
total $362 · management and general $362
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $116,253 · end of year $42,287
-
29 · Capital stock, trust principal or current funds
beginning of year $0 · end of year $0
-
30 · Paid-in or capital surplus, or land, building or equipment fund
beginning of year $0 · end of year $0
-
31 · Retained earnings, endowment or other funds
beginning of year $116,253 · end of year $42,287
Mission and programs · 2024
Mission
UTILIZE COLLECTIVE POWER TO IMPROVE THE REGULATORY, INVESTMENT, AND COMMERCIAL ENVIRONMENT FOR MICROBIOME THERAPEUTIC AND MICROBIOME-BASED PRODUCTS.
Activities or mission (Part I)
TO REPRESENT AND PROMOTE THE VOICE OF THE COMMON BUSINESS INTEREST OF MICROBIOME THERAPEUTICS AND MICROBIOME-BASED PRODUCTS TO PROVIDE GUIDANCE AND RELATED POLICIES USED TO SEEK REGULATORY CLARITY ON ISSUES INCLUDING CLINICAL TRIALS DESIGNS, ENDPOINT SELECTIONS, AND EVIDENTIAL BURDENS.
-
LOBBYING ON BEHALF OF THE COMMON BUSINESS INTEREST OF MICROBIOME THERAPEUTICS AND MICROBIOME-BASED PRODUCT COMPANIES.
Expenses $432,676
As filed on the 2024 return.
Listed in Part VII
-
Nikole KimesNIKOLE KIMES
CHAIRMAN
- Total calculated
- $0
- Hours/week
- 1
-
Tom FagleyTOM FAGLEY
TREASURER
- Total calculated
- $0
- Hours/week
- 1
-
Stephen ConafaySTEPHEN CONAFAY
SECRETARY
- Total calculated
- $0
- Hours/week
- 1
-
Johan Van Hylckama VliegJOHAN VAN HYLCKAMA VLIEG
VICE CHAIRMAN
- Total calculated
- $0
- Hours/week
- 1
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.
Grants on this return
No itemized grants to organizations on this return.
Provenance
- Return type
- form_990
- Tax year
- 2024
- Filed
- 2 April 2025
- IRS schema version
- 2024v5.1
- Source object
- 202531069349300913
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.